Abbott Laboratories manufactures and sells health care products worldwide. The company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The company was founded in 1888 and is based in Abbott Park, Illinois.
ABT Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Abbott Laboratories. To summarize, we found that Abbott Laboratories ranked in the 21th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for ABT, they are:
As a business, ABT is generating more cash flow than 91.27% of positive cash flow stocks in the Healthcare.
The business' balance sheet suggests that 9% of the company's capital is sourced from debt; this is greater than only 22.05% of the free cash flow producing stocks we're observing.
ABT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 37.98% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Abbott Laboratories? See TMO, VIVO, WST, BAX, and DHR.
The latest updated report on the Global Electrophysiology Devices Market added by Reports and Data presents a comprehensive analysis of the industry size, revenue forecast, regional spectrum of the business vertical, and further elaborates on the major hurdles, challenges, and
Editors' Note: This is the transcript of the podcast we posted last week. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below, if you need any clarification. We hope you enjoy. Sign up for Let's...
Let's Talk ETFs on Seeking Alpha | September 30, 2020
Emergency Medical Supplies Market - Industry Dynamics, Market Size, Opportunity And Forecast To 2026, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive
This article provides an update to the article I wrote in March: Since my March article, several changes have been made to the Dividend Aristocrats, and the stock market has mostly recovered from the crash in late February and early March. There are now 65 Dividend Aristocrats and, given growing...